As shown in Figure 3A, riluzole-treated cells had increased linker phosphorylation of Smad2 at serines 245/250/255 in the five melanoma cell lines tested and of Smad3 at serine 204 in all but the 1205LU cell line. The gene discussed is SMAD2; the disease is melanoma.